Literature DB >> 1333009

Calcium metabolism in Williams-Beuren syndrome.

K Kruse1, R Pankau, A Gosch, K Wohlfahrt.   

Abstract

Increased 1,25-dihydroxyvitamin D levels and decreased basal and calcium-stimulated calcitonin serum levels have been found in children with Williams-Beuren syndrome (WBS). To determine whether isolated or combined disturbances of secretion or action of the calcium-regulating hormones may cause the tendency to hypercalcemia in WBS, we investigated several aspects of calcium metabolism in 27 normocalcemic children and adults, aged 2 to 47 years, with WBS. With the exception of slightly decreased 25-hydroxyvitamin D and slightly increased calcitonin in serum, all measured basal indexes of calcium and bone metabolism, including the serum levels of intact parathyroid hormone and 1,25-dihydroxyvitamin D, were comparable to control values. Total and extractable calcitonin, the latter representing the monomeric and biologically important form of the hormone, showed the same relative increase after a low-dose calcium infusion in patients and control subjects, indicating a normal capacity of the calcitonin-producing C cells of the thyroid gland in WBS. Furthermore, exogenous parathyroid hormone induced a normal response of 1,25-dihydroxyvitamin D, cyclic adenosine monophosphate, and phosphate excretion, indicating a normal response of the renal 25-hydroxyvitamin D-1 alpha-hydroxylase and the renal receptor-adenylate cyclase system to parathyroid hormone. These findings suggest that neither deficient calcitonin secretion nor increased renal sensitivity to parathyroid hormone is a feature of WBS in normocalcemic patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333009     DOI: 10.1016/s0022-3476(05)80336-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  2 in total

1.  Hypercalcemia in Patients with Williams-Beuren Syndrome.

Authors:  Sampat Sindhar; Michael Lugo; Mark D Levin; Joshua R Danback; Benjamin D Brink; Eric Yu; Dennis J Dietzen; Amy L Clark; Carolyn A Purgert; Jessica L Waxler; Robert W Elder; Barbara R Pober; Beth A Kozel
Journal:  J Pediatr       Date:  2016-08-26       Impact factor: 4.406

2.  Calcium metabolism in the Jansen type of metaphyseal dysplasia.

Authors:  K Kruse; C Schütz
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.